Chiedi
Documenta
Scopri
Calcola
Registrati
Registrati
Accedi
Accedi
Scopri
Metastatic PDAC: Daraxonrasib resistance is dominated by KRAS amplification, not secondary KRAS mutations - Notizie Vera Health